Rchr
J-GLOBAL ID:202201008903575427
Update date: Jan. 30, 2024
HASEGAWA MASANORI
ハセガワ マサノリ | HASEGAWA MASANORI
Affiliation and department:
Research theme for competitive and other funds (3):
- 2021 - 2024 Establishment of a novel therapy for renal cell carcinoma by induction of ferroptosis via lipo-quality modulation
- 2019 - 2021 Establishment of a novel therapy for urothelial carcinoma by ferroptosis
- 2017 - 2019 Targeting MUC1 improve the docetaxel resistance and increase the sensitivity for ferroptosis in castration resistant prostate cancer
Return to Previous Page